Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody drug conjugate (ADC) are essentially anti-cancer drugs. ADC has broad application in prostate cancer, skin cancer, leukemia, pancreatic cancer, lymphoma, renal cancer, ovarian cancer, colon cancer, multiple myeloma, lung cancer, breast cancer, glioblastoma and other cancer types.
The Americas will lead the market over the forecast period. The contribution of nanotechnology to the development of antibody drug conjugates (ADC), manufacturing processes and technological advances have contributed to the growth of the global antibody drug conjugate market in this region. The global demand for Antibody Drug Conjugates Market is expected to generate revenue of around USD 2863.51 Million by end of 2026, growing at a CAGR of around 7.3 % between 2020 and 2026.
Advances in medical technology, increased cancer rates, and increased obesity are all factors that are driving the market for antibody drug conjugates. In addition, the growing cooperation between biopharmaceuticals and research institutions will also play a role in promoting the development of antibody drug conjugates market.
The report details the trend, potential and market size of Antibody Drug Conjugates market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Drug Conjugatesmarket, defines the market attractiveness level of Antibody Drug Conjugates market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antibody Drug Conjugates industry, describes the types of Antibody Drug Conjugates market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Drug Conjugates market and the development prospects and opportunities of Antibody Drug Conjugates industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Drug Conjugates market in Chapter 13.
By Player:
Pfizer
F Hoffman-La Roche
Progenics Pharmaceuticals
Novartis AG
Seattle Genetics
Takeda Pharmaceutical
Genentech
Immunogen
Bayer Healthcare Pharmaceuticals
By Type:
Kadcyla
Adcertis
By End-User:
Blood Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antibody Drug Conjugates Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antibody Drug Conjugates Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antibody Drug Conjugates Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antibody Drug Conjugates Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antibody Drug Conjugates Market Analysis and Outlook to 2022
-
7.1 Global Antibody Drug Conjugates Consumption (2017-2022)
-
7.2 United States Antibody Drug Conjugates Consumption (2017-2022)
-
7.3 Europe Antibody Drug Conjugates Consumption (2017-2022)
-
7.4 China Antibody Drug Conjugates Consumption (2017-2022)
-
7.5 Japan Antibody Drug Conjugates Consumption (2017-2022)
-
7.6 India Antibody Drug Conjugates Consumption (2017-2022)
-
7.7 South Korea Antibody Drug Conjugates Consumption (2017-2022)
8 Region and Country-wise Antibody Drug Conjugates Market Analysis and Outlook to 2028
-
8.1 Global Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.2 United States Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.3 Europe Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.4 China Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.5 Japan Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.6 India Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.7 South Korea Antibody Drug Conjugates Consumption Forecast (2022-2028)
9 Global Antibody Drug Conjugates Market Outlook by Types and Applications to 2022
-
9.1 Global Antibody Drug Conjugates Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Kadcyla Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Adcertis Consumption and Growth Rate (2017-2022)
-
9.2 Global Antibody Drug Conjugates Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Brain Tumor Consumption and Growth Rate (2017-2022)
-
9.2.6 Global others Consumption and Growth Rate (2017-2022)
10 Global Antibody Drug Conjugates Market Outlook by Types and Applications to 2028
-
10.1 Global Antibody Drug Conjugates Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Adcertis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antibody Drug Conjugates Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Brain Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global others Consumption Forecast and Growth Rate (2022-2028)
11 Global Antibody Drug Conjugates Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antibody Drug Conjugates Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antibody Drug Conjugates Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antibody Drug Conjugates Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antibody Drug Conjugates Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Antibody Drug Conjugates Product and Service
-
14.2 F Hoffman-La Roche
-
14.2.1 F Hoffman-La Roche Company Details
-
14.2.2 F Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F Hoffman-La Roche Antibody Drug Conjugates Product and Service
-
14.3 Progenics Pharmaceuticals
-
14.3.1 Progenics Pharmaceuticals Company Details
-
14.3.2 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Progenics Pharmaceuticals Antibody Drug Conjugates Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG Antibody Drug Conjugates Product and Service
-
14.5 Seattle Genetics
-
14.5.1 Seattle Genetics Company Details
-
14.5.2 Seattle Genetics Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Seattle Genetics Antibody Drug Conjugates Product and Service
-
14.6 Takeda Pharmaceutical
-
14.6.1 Takeda Pharmaceutical Company Details
-
14.6.2 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Antibody Drug Conjugates Product and Service
-
14.7 Genentech
-
14.7.1 Genentech Company Details
-
14.7.2 Genentech Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Genentech Antibody Drug Conjugates Product and Service
-
14.8 Immunogen
-
14.8.1 Immunogen Company Details
-
14.8.2 Immunogen Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Immunogen Antibody Drug Conjugates Product and Service
-
14.9 Bayer Healthcare Pharmaceuticals
-
14.9.1 Bayer Healthcare Pharmaceuticals Company Details
-
14.9.2 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antibody Drug Conjugates
-
Figure Antibody Drug Conjugates Picture
-
Table Global Antibody Drug Conjugates Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugates Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugates Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antibody Drug Conjugates Consumption by Country (2017-2022)
-
Figure United States Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Table Europe Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure China Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Japan Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure India Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugates Consumption Forecast by Country (2022-2028)
-
Figure United States Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kadcyla Consumption and Growth Rate (2017-2022)
-
Figure Global Adcertis Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global others Consumption and Growth Rate (2017-2022)
-
Figure Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adcertis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antibody Drug Conjugates Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antibody Drug Conjugates Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antibody Drug Conjugates Product and Service
-
Table F Hoffman-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman-La Roche Antibody Drug Conjugates Product and Service
-
Table Progenics Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Progenics Pharmaceuticals Antibody Drug Conjugates Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Antibody Drug Conjugates Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Antibody Drug Conjugates Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Antibody Drug Conjugates Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Antibody Drug Conjugates Product and Service
-
Table Immunogen (Foundation Year, Company Profile and etc.)
-
Table Immunogen Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunogen Antibody Drug Conjugates Product and Service
-
Table Bayer Healthcare Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product and Service
-
